313 related articles for article (PubMed ID: 24798267)
1. Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.
Hayakawa K; Martin ET; Gudur UM; Marchaim D; Dalle D; Alshabani K; Muppavarapu KS; Jaydev F; Bathina P; Sundaragiri PR; Rajuri SD; Khatri J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
Antimicrob Agents Chemother; 2014 Jul; 58(7):3968-75. PubMed ID: 24798267
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
Hayakawa K; Marchaim D; Martin ET; Tiwari N; Yousuf A; Sunkara B; Pulluru H; Kotra H; Hasan A; Bheemreddy S; Sheth P; Lee DW; Kamatam S; Bathina P; Nanjireddy P; Chalana IK; Patel S; Kumar S; Vahia A; Ku K; Yee V; Swan J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
Antimicrob Agents Chemother; 2012 May; 56(5):2452-8. PubMed ID: 22354290
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Patel R; Gallagher JC
Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
[TBL] [Abstract][Full Text] [Related]
6. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Britt NS; Potter EM; Patel N; Steed ME
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
[TBL] [Abstract][Full Text] [Related]
7. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
8. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
[TBL] [Abstract][Full Text] [Related]
9. Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.
Patel K; Kabir R; Ahmad S; Allen SL
J Oncol Pharm Pract; 2016 Apr; 22(2):212-8. PubMed ID: 25326010
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia.
Ye JJ; Shie SS; Cheng CW; Yang JH; Huang PY; Wu TS; Lee MH; Huang CT
J Microbiol Immunol Infect; 2018 Dec; 51(6):705-716. PubMed ID: 29046248
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
[TBL] [Abstract][Full Text] [Related]
12. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
Chuang YC; Wang JT; Lin HY; Chang SC
BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779
[TBL] [Abstract][Full Text] [Related]
15. Survival of Patients With Vancomycin-Resistant Enterococcus faecium Bacteremia Treated With Conventional or High Doses of Daptomycin or Linezolid Is Associated With the Rate of Bacterial Clearance.
Chuang YC; Lin HY; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
Crit Care Med; 2018 Oct; 46(10):1634-1642. PubMed ID: 29957707
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.
Herc ES; Kauffman CA; Marini BL; Perissinotti AJ; Miceli MH
Leuk Lymphoma; 2017 Dec; 58(12):2852-2858. PubMed ID: 28402152
[TBL] [Abstract][Full Text] [Related]
17. Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience.
McKinnell JA; Arias CA
Clin Infect Dis; 2015 Sep; 61(6):879-82. PubMed ID: 26063714
[No Abstract] [Full Text] [Related]
18. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Tamma PD; Hsu AJ
Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
[TBL] [Abstract][Full Text] [Related]
19. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature.
Bender JK; Cattoir V; Hegstad K; Sadowy E; Coque TM; Westh H; Hammerum AM; Schaffer K; Burns K; Murchan S; Novais C; Freitas AR; Peixe L; Del Grosso M; Pantosti A; Werner G
Drug Resist Updat; 2018 Sep; 40():25-39. PubMed ID: 30447411
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]